title: New innovations and developments for glioma treatment.
authors.affiliation: Department of Neurosurgery, Henry Ford Health System, Hermelin Brain Tumor Center, Detroit, Michigan, USA.
authors.forename: D
authors.initials: D
authors.lastname: Croteau
authors.forename: T
authors.initials: T
authors.lastname: Mikkelsen
authors.forename: S A
authors.initials: SA
authors.lastname: Rempel
authors.forename: O
authors.initials: O
authors.lastname: Bogler
authors.forename: M
authors.initials: M
authors.lastname: Rosenblum
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D017209:Apoptosis / Q000502:physiology; D001932:Brain Neoplasms / Q000235:genetics / Q000473:pathology / Q000628:therapy*; D002465:Cell Movement; D002886:Chromosomes, Human, Pair 17 / Q000235:genetics; D018773:Genes, erbB-1 / Q000235:genetics; D015316:Genetic Therapy / Q000379:methods; D005910:Glioma / Q000235:genetics / Q000473:pathology / Q000628:therapy*; D006801:Humans; D009361:Neoplasm Invasiveness; D019635:Neurosurgical Procedures / Q000379:methods; D017354:Point Mutation / Q000235:genetics; D016133:Polymerase Chain Reaction
chemical_list: D000970:Antineoplastic Agents